Towards an understanding of barriers to condom use in rural Benin using the Health Belief Model: A cross sectional survey

Hounton, Sennen H.; Carabin, Hélène; Henderson, Neil J.
January 2005
BMC Public Health;2005, Vol. 5 Issue 1, p8
Academic Journal
Background: HIV/AIDS is the most dramatic epidemic of the century that has claimed over two decade more than 3 million deaths. Sub Saharan Africa is heavily affected and accounts for nearly 70% of all cases. Despite awareness campaigns, prevention measures and more recently promotion of anti viral regimens, the prevalence of cases and deaths is still rising and the prevalence of systematic condom use remains low, especially in rural areas. This study identifies barriers to condom use based on the Health Belief Model (HBM) in Benin, West Africa. Methods: The study was a cross-sectional survey conducted from June to July 2002. Two hundred fifty one (251) individuals were interviewed using a structured questionnaire adapted from a standardized WHO/GAP questionnaire. A logistic regression was used to identify factors associated with condom use. Results: In spite of satisfactory knowledge on HIV/AIDS transmission, participants are still at high risk of contracting the infection. Sixty three (63) percents of the interviewees reported being able to recognize infected people, and condom use during the last occasional intercourse was declared by only 36.8% of males and 47.5% of females. Based on the HBM, failure to use condom was related to its perceived lack of efficacy [OR = 9.76 (3.71-30.0)] and perceived quality [OR = 3.61 (1.31-9.91)]. Conclusions: This study identifies perceived efficacy (incomplete protective effect) and perceived utilization-related problem (any reported problem using condoms) as the main barriers to condom use. Hence, preventions strategies based on increasing perceived risk, perceived severity or adequate knowledge about HIV/AIDS may not be sufficient to induce condom use. These data will be useful in designing and improving HIV/AIDS prevention outreach programs in Sub Saharan Africa.


Related Articles

  • HIV PREVENTION AMONG MALE CLIENTS OF FEMALE SEX WORKERS IN KAOLACK, SJNEGAL: RESULTS OF A PEER EDUCATION PROGRAM. Reonard, Lori; Ndiaye, Ibrahima; Kapadia, Asha; Eisen, Geoff; Diop, Ousmane; Mboup, Souleymane; Kanki, Phyllis // AIDS Education & Prevention;Feb2000, Vol. 12 Issue 1, p21 

    This article reports the results of a peer-led HIV prevention education and condom promotion program among transport workers in Kaolack, Senegal. Men who work in Kaolack's two transportation parks as truck drivers, apprentices, and baggage handlers were identified by registered, female sex...

  • AIDS BRIEF. Alcorn, Keith // CME: Continuing Medical Education;Jun2011, Vol. 29 Issue 6, p262 

    The article discusses research concerning the use of antiretroviral treatment for reducing risk of HIV transmission. The large randomised study involves male-female couples with one HIV-positive partner. The participants from several countries including Botswana, Brazil, and India received...

  • Primary HIV Infection, Phylogenetics, and Antiretroviral Prevention. Pillay, Deenan; Fisher, Martin // Journal of Infectious Diseases;4/1/2007, Vol. 195 Issue 7, p924 

    The article discusses the highly active antiretroviral therapy (HAART) for HIV infection. HAART is the therapy, composed of multiple anti-HIV drugs prescribed to many HIV-positive people, even before they develop symptoms of AIDS. The therapy usually includes one nucleoside analog, or DNA chain...

  • Complete Protection of Neonatal Rhesus Macaques against Oral Exposure to Pathogenic Simian-Human Immunodeficiency Virus by Human Anti-HIV Monoclonal Antibodies. Ferrantelli, Flavia; Rasmussen, Robert A.; Buckley, Kathleen A.; Li, Pei-Lin; Wang, Tao; Montefiori, David C.; Katinger, Hermann; Stiegler, Gabriela; Anderson, Daniel C.; McClure, Harold M.; Ruprecht, Ruth M. // Journal of Infectious Diseases;6/15/2004, Vol. 189 Issue 12, p2167 

    Because milk-borne transmission of human immunodeficiency virus (HIV) diminishes the benefits of perinatal antiviral drug therapy in developing countries, we have developed a new strategy to prevent postnatal and, possibly, intrapartum virus transmission in a primate model. Eight neonatal rhesus...

  • WHO PUBLISHES NEW GUIDELINES ON PREVENTING MOTHER TO CHILD TRANSMISSION OF HIV.  // Indian Journal of Medical Sciences;Jul2004, Vol. 58 Issue 7, p312 

    The World Health Organization has published new guidelines underlining the effectiveness of antiretroviral drugs to prevent the transmission of HIV from seropositive mothers to their children. Although expanding access to programmes to prevent mother to child transmission presents many...

  • AIDS gel's failure calls prevention approach into question. Bolognesi, Natasha // Nature Medicine;Mar2007, Vol. 13 Issue 3, p230 

    The article reports on the failure of microbicide Ushercell in preventing HIV infection. In earlier trials, Ushercell seemed both safe and effective. However, in a large phase 3 trial of 1,333 sexually active women, the researchers discovered that more women using the gel had become infected...

  • Effectiveness of Multidrug Antiretroviral Regimens to Prevent Mother-to-Child Transmission of HIV-1 in Routine Public Health Services in Cameroon. Tchendjou, Patrice; Same-Ekobo, Chantal; Nga, Annie; Tejiokem, Mathurin; Kfutwah, Anfumbom; Nlend, Anne Njom; Tsague, Landry; Bissek, Anne Cécile; Ekoa, Daniel; Orne-Gliemann, Joanna; Rousset, Dominique; Pouillot, Régis; Dabis, François // PLoS ONE;2010, Vol. 5 Issue 4, p1 

    Background: Multidrug antiretroviral (ARV) regimens including HAART and short-course dual antiretroviral (sc-dARV) regimens were introduced in 2004 to improve Prevention of Mother-to-Child Transmission (PMTCT) in Cameroon. We assessed the effectiveness of these regimens from 6-10 weeks and 12...

  • WHEN TO START ANTIRETROVIRAL THERAPY IN ADULTS: THE RESULTS OF HPTN 052 MOVE US CLOSER TO A 'TEST-AND-TREAT' POLICY. Geffen, Nathan // Southern African Journal of HIV Medicine;Sep2011, Vol. 12 Issue 3, p9 

    When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/μl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we...

  • HAART-related nephropathies in HIV-infected patients. Daugas, Eric; Rougier, Jean-Philippe; Hill, Gary // Kidney International;Feb2005, Vol. 67 Issue 2, p393 

    HAART-related nephropathies in HIV-infected patients. There is no doubt that highly active antiretroviral therapy (HAART) has been the most important progress in the therapy of human immunodeficiency virus (HIV)-infected patients in the last decade. A growing number of observations suggest that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics